The human placenta--an alternative for studying foetal exposure.
about
Increased risk for congenital heart defects in children carrying the ABCB1 Gene C3435T polymorphism and maternal periconceptional toxicants exposureAssociations between ABCG2 gene polymorphisms and isolated septal defects in a Han Chinese populationAnthropometric, socioeconomic, and maternal health determinants of placental transfer of organochlorine compounds.Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Low amino acids affect expression of 11β-HSD2 in BeWo cells through leptin-activated JAK-STAT and MAPK pathways.Antibiotic Treatment of Dogs and Cats during Pregnancy.Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autismRatio of cord to maternal serum PCB concentrations in relation to their congener-specific physicochemical properties.ATP-binding cassette efflux transporters in human placenta.Designing drug trials: considerations for pregnant women.Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study.Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.Cannabidiol changes P-gp and BCRP expression in trophoblast cell linesAn animal model of cigarette smoke-induced in utero growth retardation.Is serum gamma-glutamyltransferase a marker of exposure to various environmental pollutants?Optimization of the matrix solid phase dispersion extraction procedure for the analysis of polybrominated diphenyl ethers in human placenta.Selected persistent organic pollutants in human placental tissue from the United States.Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy.Foetal exposure to food and environmental carcinogens in human beings.The role of the placenta in fetal exposure to heavy metals.Current toxicological aspects on drug and chemical transport and metabolism across the human placental barrier.Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy.Prediction of drug disposition on the basis of its chemical structure.Modelling of human transplacental transport as performed in Copenhagen, Denmark.Metabolomics and fetal alcohol spectrum disorder: A Mini-Review.Embryonic stem cells and the next generation of developmental toxicity testing.Mercury levels in parturient and newborns from Aveiro region, Portugal.Fluoxetine-induced toxicity results in human placental glutathione S-transferase-π (GST-π) dysfunction.Placenta-on-a-chip: a novel platform to study the biology of the human placentaPossible prenatal impact of sertraline on human placental glutathione S-transferase-π.Magnetic Nanoparticles Interact and Pass an In Vitro Co-Culture Blood-Placenta Barrier Model.Drug development for use during pregnancy: impact of the placenta
P2860
Q28385768-9CD5DCA8-6821-4FA4-BD7C-1DD6A0EC9110Q28395070-5F613FB6-6540-496D-B56D-99D38240DC30Q33724597-A67EAB98-8DEB-4CBD-BCE1-ACB91FFD3CC7Q34181630-6455DA83-309A-4A01-9CAF-B85CB9F34DB1Q34182023-51A09E21-11C7-42F0-95CE-A5AFEB92B052Q34495464-A1F83C8A-0847-4083-9F60-008364A0B74CQ34527766-09DB6EB8-A598-44A8-80DE-439575242EE1Q34633343-D857761D-A468-45C0-88C0-CEC58843772DQ34843023-65D43BBA-A2C0-4AE5-8A95-E5478E4870AAQ34999905-AE4E833B-E225-404A-AD05-E8BC525B047FQ35207114-E3E4E2B8-585F-4467-AA18-9D452024F674Q36667196-8F0D5EC4-47D4-4A33-8F94-500DC12084DAQ37178591-7003B2B9-B37D-452B-9C2F-C1A89463638FQ37352872-E65ED3F6-653C-42EB-AC65-593D9B226B34Q37445634-FF571BAE-AC26-4D4C-8596-20FE79ADADFAQ37478033-5AAE2DF6-DA52-43E0-927E-58DAC5CD589CQ37665959-3260916F-794B-42CA-897E-E449991C7848Q37714085-90709B53-29F3-438B-98B9-E325B17DFCA8Q37899282-DDD809A7-3D57-43D5-BC34-85326817C8F2Q38020353-2FA9FEE4-5F11-487C-8E53-DAD5182728B7Q38025182-2E34E154-45C2-4E65-A8C4-77588381848DQ38085053-FC567C4B-5DDF-4109-9381-6AF7BE019A29Q38086778-4084965B-568D-4445-880F-A408F72A2FCCQ38197271-F5CE965C-D79C-439A-8E24-978436B28E2DQ38661268-44D0E4E4-5304-4E83-850F-FB078912BFCDQ38698182-A01CD5C6-3805-4498-B75C-C47510020821Q38775008-85CE6DBC-DC7D-4B36-9C46-125C1867260FQ40000787-C654CC62-B9D9-4E60-95B8-275828725F65Q41668656-C0309E1D-074E-4BB1-AD1F-C5E8145C54CBQ48797271-FE819E75-2884-4268-B0E6-6E0DD227BAE2Q50002357-2B31A336-79C9-4F2E-9877-1F243F117DF1Q58392274-D56ECE74-878D-4000-A8B3-AC12EE60C705
P2860
The human placenta--an alternative for studying foetal exposure.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The human placenta--an alternative for studying foetal exposure.
@en
type
label
The human placenta--an alternative for studying foetal exposure.
@en
prefLabel
The human placenta--an alternative for studying foetal exposure.
@en
P2093
P1433
P1476
The human placenta--an alternative for studying foetal exposure
@en
P2093
Line Mathiesen
Maja Myren
P304
P356
10.1016/J.TIV.2007.05.011
P577
2007-06-07T00:00:00Z